The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

A major new initiative was launched on Tuesday (15 April) by the Wellcome Sanger Institute in collaboration with Pacific ...

A study has constructed an unprecedented pangenome map of wild and cultivated rice, and decoded the genetic architecture and ...

The global Immune Repertoire Sequencing Market, valued at US$344.2 million in 2024, is forecasted to grow at a robust CAGR of 9.6%, ...

Rady study uses PacBio long-read sequencing for RFX3 variant in adolescent patient with autism, showcasing clinical genomics ...

Bernstein analyst Eve Burstein lowered the firm’s price target on PacBio (PACB) to $1.50 from $2 and keeps an Outperform rating on the shares.

A major new initiative, launched on 15 April, will map how gene activity shapes the immune system, and could help identify new therapeutic targets for conditions such as Inflammatory Bowel Disease ...

PRISM Genomics Conference officially opened in Da Nang on April 15, marking the first time the international scientific event has been held in Vietnam.

US sequencing firm PacBio (Nasdaq: PACB) is cutting jobs and reducing spending across its business as it braces for the financial impact of new global tariffs and growing uncertainty around federal ...

Tariffs and federal research “uncertainty” are forcing this Menlo Park biotech company to lay off workers at headquarters and ...

Tariffs and federal research “uncertainty” are forcing a Peninsula company to lay off workers at headquarters and cut other ...